Allergan Faces DOJ Subpoena Over Botox

Law360, New York (March 4, 2008, 12:00 AM EST) -- Deepening Allergan Inc.'s troubles over Botox, the company disclosed Monday it has been slapped with a subpoena from the U.S. Department of Justice regarding alleged promotion of off-label uses for the popular cosmetic treatment.

The company said in a statement on its Web site that the DOJ and the United States Attorney's Office for the Northern District of Georgia had asked the company to produce documents about promotional practices involving Botox for therapeutic indications.

The subpoena broadly requests documents regarding promotional, educational and other activities relating...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.